Usa covid-19 vaccine patient Usa

FDA approves Pfizer's COVID-19 pill for emergency use

Reading now: 507
www.cidrap.umn.edu

Today the US Food and Drug Administration (FDA) approved for emergency use Pfizer's Paxlovid, the first oral pill meant to treat mild-to-moderate COVID-19 infection in patients who are at high risk of progressing to severe illness.The pill is authorized for patients ages 12 and older, and should be started within 5 days of COVID-19 symptom onset.

It could be available for US doctors to prescribe in a matter of days.The drug is highly effective: Earlier this year Pfizer shared study results that showed a 30-pill regimen reduced the risk of hospitalization or death by 88% in unvaccinated patients, and newer data suggest it is effective against the Omicron variant.Last week, the White House confirmed that the federal government had ordered

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA